Skip to main content
. Author manuscript; available in PMC: 2021 May 7.
Published in final edited form as: Ann Intern Med. 2015 Sep 15;163(6):417–426. doi: 10.7326/M14-1804

Figure 3.

Figure 3.

Sensitivity analyses.

The influence on the incremental cost-effectiveness ratio on varying ages at initial device implantation (A), RRs for heart failure hospitalization (B), incremental costs of CRT-D versus ICD (C), and battery lives of devices (D). CRT-D = cardiac resynchronization therapy combined with an ICD; ICD = implantable cardioverter-defibrillator; QALY = quality-adjusted life-year; RR = risk ratio.